R. Kent McGaughy Jr., Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 329,506 shares at $22.99 ($7.6M) on 2016-12-16, disclosed to the SEC on 2016-12-20.
Open-market purchase of $7.6M RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.99 | 164,753 | $3.8M | 50.0% |
| 2 | $22.99 | 164,753 | $3.8M | 50.0% |
| Total | $22.99 avg | 329,506 | $7.6M | 100% |
| Filing → |
| TIL | BUY | 2021-03-25 | $9.0M | — | Filing → |
| APEN | BUY | 2020-07-21 | $2.2M | — | Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |